SNT
Click for more information
0.00% 3.9¢ syntara limited

Boehringer has just started recruiting in its Phase 2A study on...

  1. quattro1
    80 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    26/09/17
    09:39
    Post #: 27454785
    Boehringer has just started recruiting in its Phase 2A study on Diabetic Retinopathy (2nd indication), bringing on one site in the US. Like the NASH trial, we should hear of the coming weeks that the 1st patient has been dosed which will trigger the €10 million milestone payment to PXS. Happy days



    https://clinicaltrials.gov/ct2/show/NCT03238963?term=BI1467335&rank=2
    PXS Price at posting: 27.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $44.17M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $66.77K 1.752M

Buyers (Bids)

No. Vol. Price($)
1 2713 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 209403 1
View Market Depth
Last trade - 14.38pm 24/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.